{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:02:59Z","timestamp":1790888579608,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009406","name":"CHU Nantes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009406","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bulcan.2026.08.007","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:22:05Z","timestamp":1790799725000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Usage des antibiotiques en post-allogreffe de CSH p\u00e9diatrique (SFGM-TC)"],"prefix":"10.1016","author":[{"given":"Pauline","family":"Mazilier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Camuset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Capelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Gonzales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Jubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Lachner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud G.","family":"L\u2019Huillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Nazon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1025-3325","authenticated-orcid":false,"given":"Vincent","family":"Servant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Charlotte","family":"Teyssier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1547-8229","authenticated-orcid":false,"given":"Audrey","family":"Grain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.bulcan.2026.08.007_bib0240","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1200\/JCO.22.02224","article-title":"Guideline for the management of fever and neutropenia in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2023\u00a0update","volume":"41","author":"Lehrnbecher","year":"2023","journal-title":"J Clin Oncol"},{"issue":"11, Supplement","key":"10.1016\/j.bulcan.2026.08.007_bib0245","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"Ateliers d\u2019harmonisation des pratiques de la SFGM-TC","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.007_bib0250","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/tid.12345","article-title":"Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Kikuchi","year":"2015","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.007_bib0255","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/bmt.2014.37","article-title":"Etiology, clinical features and outcomes of pre-engraftment and post-engraftment bloodstream infection in hematopoietic SCT recipients","volume":"49","author":"Gudiol","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"10.1016\/j.bulcan.2026.08.007_bib0260","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s00277-016-2711-1","article-title":"Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016","volume":"95","author":"Ullmann","year":"2016","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.007_bib0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/cid\/ciz1082","article-title":"Guideline for antibacterial prophylaxis administration in pediatric cancer and hematopoietic stem cell transplantation","volume":"71","author":"Lehrnbecher","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.007_bib0270","doi-asserted-by":"crossref","first-page":"528","DOI":"10.5603\/AHP.a2021.0097","article-title":"Antimicrobial prophylaxis in adults and children undergoing hematopoietic cell transplantation: 2021\u00a0Polish recommendations","volume":"52","author":"Styczynski","year":"2021","journal-title":"Acta Haematol Polonica"},{"key":"10.1016\/j.bulcan.2026.08.007_bib0275","series-title":"The EBMT Handbook: Hematopoietic Cell Transplantation and Cellular Therapies [Internet]","year":"2024"},{"issue":"4","key":"10.1016\/j.bulcan.2026.08.007_bib0280","doi-asserted-by":"crossref","first-page":"ofaa093","DOI":"10.1093\/ofid\/ofaa093","article-title":"Microbiology and risk factors for hospital-associated bloodstream infections among pediatric hematopoietic stem cell transplant recipients","volume":"7","author":"Akinboyo","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"10.1016\/j.bulcan.2026.08.007_bib0285","doi-asserted-by":"crossref","first-page":"e0284628","DOI":"10.1371\/journal.pone.0284628","article-title":"Infections and risk factors for infection-related mortality after pediatric allogeneic hematopoietic stem cell transplantation in Mexico: A single center retrospective study","volume":"18","author":"Jim\u00e9nez-Hern\u00e1ndez","year":"2023","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bulcan.2026.08.007_bib0290","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/bmt.2017.14","article-title":"Bacterial bloodstream infections in the allogeneic hematopoietic cell transplant patient: new considerations for a persistent nemesis","volume":"52","author":"Dandoy","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.007_bib0295","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020\u00a0guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.007_bib0300","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.bulcan.2018.08.017","article-title":"Prophylaxie des infections post-allogreffe\u00a0: recommandations de la Soci\u00e9t\u00e9 francophone de greffe de moelle et de th\u00e9rapie cellulaire (SFGM-TC)","volume":"106","author":"Lewalle","year":"2019","journal-title":"Bull Cancer"},{"issue":"17","key":"10.1016\/j.bulcan.2026.08.007_bib0305","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1200\/JCO.2015.65.8591","article-title":"Strategies for empiric management of pediatric fever and neutropenia in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review of randomized trials","volume":"34","author":"Robinson","year":"2016","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.007_bib0310","doi-asserted-by":"crossref","first-page":"e232","DOI":"10.1016\/S1473-3099(25)00619-X","article-title":"Empirical and targeted antimicrobial therapy in patients with febrile neutropenia and haematological malignancy or after haematopoietic cell transplantation: recommendations from the 10th European Conference on Infections in Leukaemia","volume":"26","author":"Averbuch","year":"2026","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.bulcan.2026.08.007_bib0315","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/S2352-3026(17)30211-9","article-title":"Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4\u00a0trial","volume":"4","author":"Aguilar-Guisado","year":"2017","journal-title":"Lancet Haematol"},{"issue":"4","key":"10.1016\/j.bulcan.2026.08.007_bib0320","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010\u00a0update by the Infectious Diseases Society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.bulcan.2026.08.007_bib0325","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3324\/haematol.2013.091330","article-title":"Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.bulcan.2026.08.007_bib0330","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.3390\/antibiotics10121523","article-title":"Levofloxacin versus ciprofloxacin-based prophylaxis during the pre-engraftment phase in allogeneic hematopoietic stem cell transplant pediatric recipients: a single-center retrospective matched analysis","volume":"10","author":"Servidio","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"10","key":"10.1016\/j.bulcan.2026.08.007_bib0335","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1001\/jama.2018.12512","article-title":"Effect of levofloxacin prophylaxis on bacteremia in children with acute leukemia or undergoing hematopoietic stem cell transplantation: a randomized clinical trial","volume":"320","author":"Alexander","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.bulcan.2026.08.007_bib0340","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/08880018.2024.2353888","article-title":"Levofloxacin prophylaxis in pediatric oncology and hematopoietic stem cell transplantation: a literature review","volume":"41","author":"Koo","year":"2024","journal-title":"Pediatr Hematol Oncol"},{"issue":"2S","key":"10.1016\/j.bulcan.2026.08.007_bib0345","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.bulcan.2023.05.007","article-title":"[Vaccination of allogeneic haematopoietic stem cell transplant recipients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]","volume":"111","author":"Conrad","year":"2024","journal-title":"Bull Cancer"},{"issue":"2","key":"10.1016\/j.bulcan.2026.08.007_bib0350","doi-asserted-by":"crossref","first-page":"176.e1","DOI":"10.1016\/j.jtct.2020.10.009","article-title":"Clostridioides difficile infection and risk of acute graft-versus-host disease among allogeneic hematopoietic stem cell transplantation recipients","volume":"27","author":"Jabr","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"8","key":"10.1016\/j.bulcan.2026.08.007_bib0355","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/cid\/cir1035","article-title":"Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients","volume":"54","author":"Alonso","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bulcan.2026.08.007_bib0360","unstructured":"CT-18671_DIFICLIR_PIC_EI_AvisDef_CT18670&18671.pdf [Internet]. [cit\u00e9 28\u00a0nov 2025]. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-18671_DIFICLIR_PIC_EI_AvisDef_CT18670&18671.pdf."},{"key":"10.1016\/j.bulcan.2026.08.007_bib0365","doi-asserted-by":"crossref","first-page":"102604","DOI":"10.1016\/j.eclinm.2024.102604","article-title":"Guideline for the management of Clostridioides difficile infection in pediatric patients with cancer and hematopoietic cell transplantation recipients: 2024\u00a0update","volume":"72","author":"Patel","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"5","key":"10.1016\/j.bulcan.2026.08.007_bib0370","doi-asserted-by":"crossref","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021\u00a0focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.bulcan.2026.08.007_bib0375","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European Society of Clinical Microbiology and Infectious Diseases: 2021\u00a0update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"van\u00a0Prehn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.bulcan.2026.08.007_bib0380","unstructured":"Haute Autorit\u00e9 de sant\u00e9 [Internet]. [cit\u00e9 23\u00a0janv 2026]. DIFICLIR (fidaxomicine) - Infection \u00e0 Clostridium difficile. Disponible sur\u00a0: https:\/\/www.has-sante.fr\/jcms\/p_3498127\/fr\/dificlir-fidaxomicine-infection-a-clostridium-difficile."},{"key":"10.1016\/j.bulcan.2026.08.007_bib0385","doi-asserted-by":"crossref","first-page":"102111","DOI":"10.1016\/j.eclinm.2023.102111","article-title":"Pooled allogeneic faecal microbiota MaaT013\u00a0for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2\u00a0trial","volume":"62","author":"Malard","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"9","key":"10.1016\/j.bulcan.2026.08.007_bib0390","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/bloodadvances.2024012556","article-title":"Third-party fecal microbiota transplantation for high-risk treatment-na\u00efve acute GVHD of the lower GI tract","volume":"8","author":"DeFilipp","year":"2024","journal-title":"Blood Adv"},{"issue":"18","key":"10.1016\/j.bulcan.2026.08.007_bib0395","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.3390\/cancers13184665","article-title":"Gut microbiome modulation and faecal microbiota transplantation following allogenic hematopoietic stem cell transplantation","volume":"13","author":"Ka\u017amierczak-Siedlecka","year":"2021","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.bulcan.2026.08.007_bib0400","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000538303","article-title":"Fecal microbiota transfer in acute graft-versus-host disease following allogeneic stem cell transplantation","volume":"40","author":"Weber","year":"2024","journal-title":"Visc Med"},{"key":"10.1016\/j.bulcan.2026.08.007_bib0405","doi-asserted-by":"crossref","first-page":"964005","DOI":"10.3389\/fphar.2022.964005","article-title":"Dose optimization of \u03b2-lactams antibiotics in pediatrics and adults: A systematic review","volume":"13","author":"Haseeb","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bulcan.2026.08.007_bib0410","unstructured":"CASFM2025_V1.1-JUILLET-2025.pdf [Internet]. [cit\u00e9 28\u00a0janv 2026]. Disponible sur\u00a0: https:\/\/www.sfm-microbiologie.org\/wp-content\/uploads\/2025\/07\/CASFM2025_V1.1-JUILLET-2025.pdf."},{"issue":"3","key":"10.1016\/j.bulcan.2026.08.007_bib0415","first-page":"123","article-title":"D\u00e9finitions et implications des param\u00e8tres pharmacocin\u00e9tiques-pharmacodynamiques des antibiotiques en pratique clinique p\u00e9diatrique","volume":"37","author":"Cohen","year":"2024","journal-title":"J Pediatr Puericult"},{"issue":"3","key":"10.1016\/j.bulcan.2026.08.007_bib0420","first-page":"115","article-title":"Principes de l\u2019antibioth\u00e9rapie curative","volume":"37","author":"Cohen","year":"2024","journal-title":"J Pediatr Puericult"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.007_bib0425","doi-asserted-by":"crossref","first-page":"105018","DOI":"10.1016\/j.idnow.2024.105018","article-title":"Intravenous administration of antibiotics by prolonged and continuous infusion","volume":"55","author":"Ourghanlian","year":"2025","journal-title":"Infect Dis Now"},{"issue":"4","key":"10.1016\/j.bulcan.2026.08.007_bib0430","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1097\/INF.0000000000003457","article-title":"Searching high and low: call for a Joint European Society for Paediatric Infectious Diseases-European Committee on Antimicrobial Susceptibility Testing Survey on dosage of antibacterial agents in children\u2014Part One","volume":"41","author":"Aguilera-Alonso","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"10.1016\/j.bulcan.2026.08.007_bib0435","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/cid\/cis580","article-title":"Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"55","author":"Taur","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.bulcan.2026.08.007_bib0440","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.bbmt.2014.01.030","article-title":"Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease","volume":"20","author":"Holler","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.007_bib0445","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s40168-021-01100-2","article-title":"Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation","volume":"9","author":"Ingham","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/j.bulcan.2026.08.007_bib0450","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.trim.2025.102199","article-title":"Gut microbiota variation and diversity and gut graft-versus-host disease (GVHD) in pediatrics: A systematic review","volume":"89","author":"Sohouli","year":"2025","journal-title":"Transpl Immunol"},{"issue":"339","key":"10.1016\/j.bulcan.2026.08.007_bib0455","doi-asserted-by":"crossref","first-page":"339ra71","DOI":"10.1126\/scitranslmed.aaf2311","article-title":"Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice","volume":"8","author":"Shono","year":"2016","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.bulcan.2026.08.007_bib0460","doi-asserted-by":"crossref","first-page":"e1258506","DOI":"10.1080\/2162402X.2016.1258506","article-title":"The influence of gut-decontamination prophylactic antibiotics on acute graft-versus-host disease and survival following allogeneic hematopoietic stem cell transplantation","volume":"6","author":"Routy","year":"2017","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.bulcan.2026.08.007_bib0465","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40262-025-01495-3","article-title":"Variability in meropenem distribution and clearance in children with sepsis: population-based pharmacokinetics with assessment of renal biomarkers","volume":"64","author":"Le","year":"2025","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"10.1016\/j.bulcan.2026.08.007_bib0235","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"Rybak","year":"2020","journal-title":"Am J Health Syst Pharm"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126004078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126004078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:46:29Z","timestamp":1790887589000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126004078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":47,"alternative-id":["S0007455126004078"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.08.007","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usage des antibiotiques en post-allogreffe de CSH p\u00e9diatrique (SFGM-TC)","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}